TechTissue - Validate human-based 3D in vitro models for accurate drug discovery...
TechTissue - Validate human-based 3D in vitro models for accurate drug discovery and development towards a successful market entry
Metatissue is focused on the design, production and commercialization of chemically modified human-derived proteins to prepare hydrogels, sponges and bioinks to improve 3D cell culture and disease modelling for drug discovery and...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SILKink
Revolutionary silk-based bioink for 3D printing of ex vivo b...
2M€
Cerrado
HumanINK
Human based bioinks to engineer physiologically relevant tis...
150K€
Cerrado
AnisoPlate
High-throughput production of anisotropic 3D human tissue mo...
150K€
Cerrado
GUT3D-PLATE
Ready to use cell culture plates for gut 3D models
150K€
Cerrado
OPTIMIsE
Commercial feasibility of the Novio PlainGel a novel synthe...
71K€
Cerrado
PGC2018-097323-A-I00
FABRICACION DE ALTO RENDIMIENTO DE DISPOSITIVOS BIOMECATRONI...
67K€
Cerrado
Información proyecto TechTissue
Duración del proyecto: 12 meses
Fecha Inicio: 2022-05-16
Fecha Fin: 2023-05-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Metatissue is focused on the design, production and commercialization of chemically modified human-derived proteins to prepare hydrogels, sponges and bioinks to improve 3D cell culture and disease modelling for drug discovery and development, tissue engineering, and personalized medicine advancements.
Metatissue has developed a bioactive platelet-rich plasma derivative precursor that can be cured upon light exposure to form soft materials with tunable mechanical properties. Such materials provide functional support for cell growth and interact with cells to control their function, guiding the process of tissue morphogenesis. This platform is the first to offer complete human-based material for 3D cell culture and an easy-to-use solution for clinical purposes.
This deep technology enables researchers to culture human cells in a physiologically relevant microenvironment for applications in cell culture research, drug screening and development, cancer research, tissue engineering, replacement of animal testing and therapeutic applications. This technology will have a significant impact on the 3D cell culture market and pharmaceutical industry by accelerating drug screening and development reducing associated costs.These materials present an alternative to the gold standard materials that are currently used in cell culture assays, which generally comprise animal-derived proteins that form a gel under corporal conditions.
TechTissue intend to achieve the current Metatissue strategy by exploiting its business opportunity and setting a successful business strategy and commercialization plan based on the technical optimisation of the product, the assessed market requirements, the end-user needs and the competitor analysis.